DE60322717D1 - Verfahren zum screening von antiligand-bibliotheken zur identifizierung von antiliganden, die spezifisch für unterschiedliche und selten experimierte liganden sind - Google Patents

Verfahren zum screening von antiligand-bibliotheken zur identifizierung von antiliganden, die spezifisch für unterschiedliche und selten experimierte liganden sind

Info

Publication number
DE60322717D1
DE60322717D1 DE60322717T DE60322717T DE60322717D1 DE 60322717 D1 DE60322717 D1 DE 60322717D1 DE 60322717 T DE60322717 T DE 60322717T DE 60322717 T DE60322717 T DE 60322717T DE 60322717 D1 DE60322717 D1 DE 60322717D1
Authority
DE
Germany
Prior art keywords
ligands
ligand
providing
target
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322717T
Other languages
English (en)
Inventor
Bjoern Frendeus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioinvent International AB
Original Assignee
Bioinvent International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent International AB filed Critical Bioinvent International AB
Application granted granted Critical
Publication of DE60322717D1 publication Critical patent/DE60322717D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60322717T 2002-09-04 2003-09-03 Verfahren zum screening von antiligand-bibliotheken zur identifizierung von antiliganden, die spezifisch für unterschiedliche und selten experimierte liganden sind Expired - Lifetime DE60322717D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0220506A GB2392723B (en) 2002-09-04 2002-09-04 Screening methods
PCT/EP2003/009991 WO2004023140A1 (en) 2002-09-04 2003-09-03 Method for screening anti-ligand libraries for identifying anti-ligands specific for differentially and infrequently expressed ligands

Publications (1)

Publication Number Publication Date
DE60322717D1 true DE60322717D1 (de) 2008-09-18

Family

ID=9943455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322717T Expired - Lifetime DE60322717D1 (de) 2002-09-04 2003-09-03 Verfahren zum screening von antiligand-bibliotheken zur identifizierung von antiliganden, die spezifisch für unterschiedliche und selten experimierte liganden sind

Country Status (11)

Country Link
US (3) US8592347B2 (de)
EP (1) EP1535069B1 (de)
AT (1) ATE403865T1 (de)
AU (1) AU2003266366A1 (de)
DE (1) DE60322717D1 (de)
DK (1) DK1535069T3 (de)
ES (1) ES2314280T3 (de)
GB (1) GB2392723B (de)
PT (1) PT1535069E (de)
SI (1) SI1535069T1 (de)
WO (1) WO2004023140A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392723B (en) * 2002-09-04 2005-01-12 Bioinvent Int Ab Screening methods
GB0525214D0 (en) 2005-12-12 2006-01-18 Bioinvent Int Ab Biological materials and uses thereof
GB201116364D0 (en) * 2011-09-22 2011-11-02 Bioinvent Int Ab Screening methods and uses thereof
KR101580360B1 (ko) * 2013-05-22 2015-12-28 김성천 연자성미세구조물을 이용한 리간드의 스크리닝 시스템 및 그 용도
US10018635B2 (en) * 2014-07-30 2018-07-10 Novilytic, LLC Method for analyzing samples of a biological fluid
WO2023242125A1 (en) 2022-06-13 2023-12-21 Bioinvent International Ab Methods of isolating anti-ligands

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366862A (en) * 1990-02-14 1994-11-22 Receptor Laboratories, Inc. Method for generating and screening useful peptides
AU8081491A (en) 1990-06-01 1991-12-31 Cetus Corporation Compositions and methods for identifying biologically active molecules
AU1378495A (en) * 1993-12-27 1995-07-17 Hamilton Civic Hospitals Research Development, Inc. Methods and compositions for inhibiting thrombogenesis
US6794128B2 (en) * 1998-04-24 2004-09-21 The Regents Of The University Of California Methods of selecting internalizing antibodies
WO2000052054A2 (en) * 1999-03-01 2000-09-08 Genentech, Inc. Antibodies for cancer therapy and diagnosis
US7135287B1 (en) * 1999-10-02 2006-11-14 Biosite, Inc. Human antibodies
US20050130320A1 (en) * 2000-11-09 2005-06-16 George Shaji. T. Method for identifying the proteome of cells using an antibody library microarray
GB2392723B (en) 2002-09-04 2005-01-12 Bioinvent Int Ab Screening methods
US20090005257A1 (en) 2003-05-14 2009-01-01 Jespers Laurent S Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire
CN101333243A (zh) 2003-05-14 2008-12-31 多曼蒂斯有限公司 从多肽全能文库恢复可逆可解折叠多肽的方法
US20110052565A1 (en) 2007-12-21 2011-03-03 National Research Council Of Canada Non-aggregating human vh domains
GB201116364D0 (en) 2011-09-22 2011-11-02 Bioinvent Int Ab Screening methods and uses thereof

Also Published As

Publication number Publication date
US8592347B2 (en) 2013-11-26
DK1535069T3 (da) 2008-11-10
ES2314280T3 (es) 2009-03-16
US20140200152A1 (en) 2014-07-17
AU2003266366A1 (en) 2004-03-29
ATE403865T1 (de) 2008-08-15
GB2392723A (en) 2004-03-10
EP1535069A1 (de) 2005-06-01
WO2004023140A1 (en) 2004-03-18
GB2392723B (en) 2005-01-12
PT1535069E (pt) 2008-10-08
US20060199219A1 (en) 2006-09-07
US20160312383A1 (en) 2016-10-27
SI1535069T1 (sl) 2008-12-31
US10351970B2 (en) 2019-07-16
GB0220506D0 (en) 2002-10-09
EP1535069B1 (de) 2008-08-06

Similar Documents

Publication Publication Date Title
DE60230927D1 (de) Fangverbindungen, ihre entnahme und verfahren zur analysierung des proteoms und von komplexen zusammensetzungen
WO2003100012A3 (en) Microarrays and method for running hybridization reaction for multiple samples on a single microarray
CA2413978A1 (en) Multianalyte molecular analysis
ATE549414T1 (de) Verfahren zur isolierung von zellen
DE69831179D1 (de) Tragbare vorrichtung zur simulation von bidirektionellen verbindungen für ein-direktionelle datenströme
ATE491042T1 (de) Vorrichtung und verfahren zur quantifizierung von mrna aus vollblut mit hohem durchsatz
DE60325847D1 (de) Verbindungen und verfahren für die analyse des proteoms
DE69840112D1 (de) Verfahren zur Sichtung von Phagen-Display-Bibliotheken mit unterschiedlichen Liganden
ATE419521T1 (de) Vorrichtung und verfahren zur mikrofluidischen matrixortung
ATE470722T1 (de) Strategien zur genexpressionsanalyse
WO2007006661A3 (en) System and method for characterizing a chemical sample
WO2002088396A3 (en) Reagents and methods for automated in situ or microarray hybridization
DE602004020605D1 (de) Verfahren und vorrichtung zur entfernung von organ
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
WO2004011607A3 (en) Reagent and method for determination of a substance using an immunoaggregator
DE60322717D1 (de) Verfahren zum screening von antiligand-bibliotheken zur identifizierung von antiliganden, die spezifisch für unterschiedliche und selten experimierte liganden sind
EP1627038A4 (de) Biochipsysteme auf mikropartikelbasis und verwendungen davon
DE60202008D1 (de) Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten
WO2002037102A3 (en) Methods for analyzing dynamic changes in cellular informatics
DE69414122D1 (de) Verfahren zum nachweis biologischer wechselwirkungen, insbesondere in rezeptorbindungs-assays
DE60130211D1 (de) Matrix-screening-verfahren
DE69628554D1 (de) Chlamydia-pneumoniae-antigen, verfahren zu seiner herstellung, verfahren zur testung von anti-chlamydia-pneumoniae-antikörper durch seine verwendung und reagenz zum testen von anti-chlamydia-pneumoniae-antikörper
ATE405592T1 (de) Verfahren zur bildung eines protein- mikroarraysystems
JP2008544232A5 (de)
SE0301058D0 (sv) Method and kit for cell analyte assay

Legal Events

Date Code Title Description
8364 No opposition during term of opposition